CRISPR hires William Blair an­a­lyst as new fi­nance chief; Tiny EU biotech rais­es $20M+

Less than 18 months af­ter hir­ing Bren­dan Smith as CFO, CRISPR Ther­a­peu­tics is bring­ing in an­oth­er ex­ec to take his place.

The Swiss-Amer­i­can gene edit­ing biotech put out word Mon­day that it is hir­ing Ra­ju Prasad as the com­pa­ny’s newest fi­nance chief, ef­fec­tive Tues­day. Prasad joins from in­vest­ment bank William Blair, where he was a se­nior re­search an­a­lyst cov­er­ing gene edit­ing and gene and cell ther­a­py.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER